22 results
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... Bezlotoxumab 10 mg/kg IV ... IDSA 2021 CDI ... #Cdiff #Clostridioides ... #treatment #infectiousdiseases
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... difficile Infection (CDI ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
for Preventing ... patients with CD4 ... #Prevention #Treatment ... #opportunistic ... infections #HIVAIDS #management
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... leishmaniasis and CD4 ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... restoration to CD4 ... Aggressive oral and/or IV ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... amphotericin B at 3 mg/kg IV ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... • Since low CD4 ... valganciclovir or IV ... #Prevention #Treatment ... #management #opportunistic